MetaCap

Who Owns Compass Therapeutics Stock?

NASDAQ: CMPXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.6882+0.0097 (+1.43%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
85.75%
Institutional holders
218
  • Institutions 85.7%
  • Insiders 12.5%
  • Public and other 1.8%

Who owns Compass Therapeutics stock?

Institutional investors own about 85.7% of Compass Therapeutics's shares, spread across 218 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 12.47% of CMPX.

The largest institutional holders are Tang Capital Management, LLC (34.52%), Orbimed Advisors LLC. (29.20%) and Montanova Capital LLC (27.49%). Together, the top 10 institutions control 185.1% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their CMPX positions and 3 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of CMPX

Compass Therapeutics top institutional holders
InstitutionShares% HeldChange
Tang Capital Management, LLC17.99M34.52%0.0%
Orbimed Advisors LLC.15.22M29.20%0.0%
Montanova Capital LLC14.33M27.49%+1.6%
Blackrock Inc.11.39M21.86%+1.0%
Enavate Sciences Gp, LLC 7.79M14.94%0.0%
State Street Corporation7.74M14.85%-22.3%
Palo Alto Investors Lp7.15M13.71%+22.6%
Vanguard Capital Management LLC5.99M11.50%-2.0%
Millennium Management Llc4.69M8.99%-0.6%
Qube Research & Technologies Ltd4.17M8.00%+13.1%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of CMPX

Compass Therapeutics top fund holders
FundShares% Held
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF4.81M9.22%
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund4.19M8.04%
iShares Trust-iShares Russell 2000 ETF3.48M6.67%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund1.79M3.44%
Fidelity Commonwealth Trust II-Fidelity Enhanced Small Cap Core ETF1.61M3.10%
iShares Trust-iShares Russell 2000 Value ETF1.22M2.34%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund1.06M2.03%
Vanguard Explorer Fund962.80K1.85%
VANGUARD VARIABLE INSURANCE FUNDS-Small Company Growth Portfolio775.00K1.49%
VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund752.67K1.44%

Frequently asked questions

Who is the largest shareholder of Compass Therapeutics?

Tang Capital Management, LLC is the largest institutional shareholder of CMPX, owning 34.52% of shares outstanding (17.99M shares) as of its latest 13F filing.

What percentage of Compass Therapeutics is owned by institutions?

Institutions own about 85.7% of CMPX shares and 98.0% of the public float.

How much of Compass Therapeutics do insiders own?

Insiders, such as officers and directors, own about 12.47% of CMPX shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related